Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.

Guests

  • Gardiner Harris Science reporter for "The New York Times"
  • Alan Goldhammer, PhD Associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
  • Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
  • William Hubbard Former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Untangling The Lies Of Rep. George Santos

Thursday, Jan 19 2023Behind the lies of Congressman George Santos. Diane talks to the owner of the small weekly paper that first broke the story, and a Washington Post journalist who is following the money to see who financed Santos's political rise.